Falusi Fanni, Budai-Szűcs Mária, Csányi Erzsébet, Berkó Szilvia, Spaits Tamás, Csóka Ildikó, Kovács Anita
Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 6 Eötvös St. Szeged H-6720, Hungary.
EGIS Pharmaceuticals PLC, 65 Mátyás király str. Körmend H-9900, Hungary.
Eur J Pharm Sci. 2022 Jun 1;173:106160. doi: 10.1016/j.ejps.2022.106160. Epub 2022 Mar 4.
Dermal foams are promising drug delivery systems due to their many advantages and ease of application. Foams are also considered a novelty in the field of dermatology. In particular, they are beneficial for the treatment of skin conditions where patients have highly inflamed, swollen, infected and sensitive skin, as the application of the foam to the skin surface to be treated minimizes the need for skin contact. In order to formulate foams, it is necessary to know which material and process parameters influence the quality characteristics of foams and which methods can be used to study foams; this part of the research is assisted by the QbD approach. By using the QbD concept, it contributed during the development process to ensure quality-based development. With initial risk assessment, the critical material attributes (CMAs) and the critical process parameters (CPPs) were identified to ensure the required critical quality attributes (CQAs). During the initial risk assessment, five high-risk CQAs, namely foam volume stability, foam expansion, cross point, the initial values of the number and size of bubbles, and three medium-risk CQAs, namely spreadability, relative foam density and viscosity of the liquid system were identified and investigated. In this research, different types of polymers (xanthan gum, hydroxyethylcellulose, different types of hyaluronic acids) were used to improve the properties of foam formulations. The formulations containing xanthan gum and high molecular weight hyaluronic acid had good foam properties and will be appropriate delivery systems for an active pharmaceutical ingredient. Overall, the polymer content had a great effect on the properties of the foams. Different polymers affect the properties of foams in different ways. When used in combination, the methods reinforce each other and help to select a formula for dermal application.
由于具有诸多优点且易于应用,皮肤泡沫剂是很有前景的药物递送系统。泡沫剂在皮肤病学领域也被视为一种新事物。特别是,它们对于治疗皮肤高度发炎、肿胀、感染和敏感的皮肤状况有益,因为将泡沫剂应用于待治疗的皮肤表面可减少皮肤接触的需求。为了制备泡沫剂,有必要了解哪些材料和工艺参数会影响泡沫剂的质量特性以及可用于研究泡沫剂的方法;这部分研究可借助质量源于设计(QbD)方法来辅助。通过使用QbD概念,它在开发过程中有助于确保基于质量的开发。通过初始风险评估,确定了关键物料属性(CMA)和关键工艺参数(CPP),以确保所需的关键质量属性(CQA)。在初始风险评估期间,确定并研究了五个高风险CQA,即泡沫体积稳定性、泡沫膨胀、交叉点、气泡数量和尺寸的初始值,以及三个中风险CQA,即可铺展性、相对泡沫密度和液体系统的粘度。在本研究中,使用了不同类型的聚合物(黄原胶、羟乙基纤维素、不同类型的透明质酸)来改善泡沫制剂的性能。含有黄原胶和高分子量透明质酸的制剂具有良好的泡沫性能,将是活性药物成分的合适递送系统。总体而言,聚合物含量对泡沫的性能有很大影响。不同的聚合物以不同的方式影响泡沫的性能。当组合使用时,这些方法相互加强,有助于选择用于皮肤应用的配方。